Fluorine in PDB 7bjm: Crystal Structure of CHK1-10PT-Mutant Complex with Compound 10

Enzymatic activity of Crystal Structure of CHK1-10PT-Mutant Complex with Compound 10

All present enzymatic activity of Crystal Structure of CHK1-10PT-Mutant Complex with Compound 10:
2.7.11.1;

Protein crystallography data

The structure of Crystal Structure of CHK1-10PT-Mutant Complex with Compound 10, PDB code: 7bjm was solved by P.Dokurno, A.E.Surgenor, D.S.Williamson, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 20.00 / 2.30
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 44.93, 65.95, 54.29, 90, 101.31, 90
R / Rfree (%) 17.5 / 23.1

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of CHK1-10PT-Mutant Complex with Compound 10 (pdb code 7bjm). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Crystal Structure of CHK1-10PT-Mutant Complex with Compound 10, PDB code: 7bjm:

Fluorine binding site 1 out of 1 in 7bjm

Go back to Fluorine Binding Sites List in 7bjm
Fluorine binding site 1 out of 1 in the Crystal Structure of CHK1-10PT-Mutant Complex with Compound 10


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of CHK1-10PT-Mutant Complex with Compound 10 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F301

b:105.8
occ:1.00
F1 A:TW2301 0.0 105.8 1.0
C9 A:TW2301 1.4 105.4 1.0
C8 A:TW2301 2.4 106.5 1.0
C4 A:TW2301 2.4 103.3 1.0
O A:HOH488 2.8 74.1 1.0
C3 A:TW2301 2.8 94.6 1.0
N3 A:TW2301 2.9 69.1 1.0
C11 A:TW2301 3.4 69.1 1.0
C7 A:TW2301 3.6 107.4 1.0
C5 A:TW2301 3.6 107.4 1.0
CB A:ASP148 4.0 45.9 1.0
N2 A:TW2301 4.1 89.1 1.0
C6 A:TW2301 4.1 109.1 1.0
CG A:ASP148 4.2 49.1 1.0
C10 A:TW2301 4.4 70.3 1.0
OD2 A:ASP148 4.4 56.1 1.0
CG2 A:VAL23 4.5 87.4 1.0
C2 A:TW2301 4.6 77.6 1.0
CA A:ASP148 4.6 43.1 1.0
OD1 A:ASP148 4.7 53.0 1.0

Reference:

D.S.Williamson, G.P.Smith, G.K.Mikkelsen, T.Jensen, P.Acheson-Dossang, L.Badolo, S.T.Bedford, V.Chell, I.J.Chen, P.Dokurno, M.Hentzer, S.Newland, S.C.Ray, T.Shaw, A.E.Surgenor, L.Terry, Y.Wang, K.V.Christensen. Design and Synthesis of Pyrrolo[2,3- D ]Pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using A Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate. J.Med.Chem. 2021.
ISSN: ISSN 0022-2623
PubMed: 34184879
DOI: 10.1021/ACS.JMEDCHEM.1C00720
Page generated: Sat Jul 10 14:02:46 2021

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy